Australia Pharmaceutical Licensing

Australian compliance involves at least four layers: ARTG/sponsor, TGA manufacturing, state/territory premises and controlled-drug activities, and individual pharmacist registration. Company incorporation or a single authorisation does not cover all activities.

Foreign investors or overseas groups do not automatically obtain pharmaceutical licences. Certain actions involving Australian businesses/assets may separately require notification to the Treasurer under foreign investment rules; this is transaction review and does not replace TGA or state-level authorisation.

— Establish a licensing matrix by product, activity, site and operating state/territory.

— Separately check foreign investment transactions against Foreign Investment Australia guidance.

Swipe horizontally to view all items

The TGA is responsible for therapeutic goods, the ARTG, Australian manufacturing licences and GMP; its information indicates that domestic manufacturing usually requires a licence or compliance with an assessment certificate.

The Pharmacy Board/Ahpra administers individual professional registration; state/territory authorities regulate pharmacy premises and the supply of medicines/poisons; the ODC administers cross-border permits for specified controlled substances.

— Products, sites, individuals and controlled substances must be checked separately with the relevant authorities.

Swipe horizontally to view all items

Community pharmacy premises, business operations and ownership are not covered together by a national TGA retail licence. NSW states that obtaining, wholesaling and retailing medicines/poisons usually require state authorisation, and also lists exceptions allowing pharmacists to obtain medicines for a pharmacy or supply S2, 3, 4, 8 to individual patients. Its non-pharmacy S2 retail authorisation has a specific scope and cannot be treated as the ordinary community pharmacy pathway.

Victoria is a local example: the VPA administers pharmacy business licences and premises registration, and states that pharmacies there must be owned, operated and controlled by registered pharmacists, with a registered pharmacist personally supervising while open; these requirements apply only in Victoria.

— First distinguish community pharmacies, hospital pharmacy departments, depots and non-pharmacy retail.

— Obtain premises/business authorisation and individual professional registration separately.

Swipe horizontally to view all items

The TGA's Code of Good Wholesaling Practice for Medicines covers manufacturers, agents, importers, distributors and 3PLs that store or supply S2, 3, 4, 8 medicines wholesale. The Code is not legislation; it is implemented through state/territory laws or local licensing arrangements, so it cannot be described as a national TGA wholesale licence.

The Queensland example indicates that premises storing medicines for wholesale must have a Substance Management Plan; applications are assessed for company officers, partners, sole traders and responsible persons, and changes to relevant persons require a new form. NSW also states that a wholesale licence is generally required to wholesale specified schedules from an NSW site.

— Establish SOPs for labelled storage, temperature control, segregation, recalls, transport and security.

— Check local authorisation for each warehouse, 3PL and actual wholesale activity.

Swipe horizontally to view all items

The TGA states that, except where an exemption applies, it is unlawful to manufacture therapeutic goods for human use without a licence; only Australian sites can obtain a TGA manufacturing licence. Manufacturing may include production, processing, packaging, labelling, storage, testing and release.

An overseas factory does not obtain an Australian manufacturing licence; instead, its Australian sponsor/agent follows the applicable GMP certification or clearance pathway. Batches manufactured without a licence/certification must not be supplied or exported unless approval is obtained first.

— Confirm manufacturing steps, product categories, dosage forms and GMP readiness for each site.

— Assess pharmacy compounding only if all exemption conditions are met.

Swipe horizontally to view all items

Individual registration with the Pharmacy Board/Ahpra determines whether a person may practise as a pharmacist; it does not constitute company manufacturing, wholesale or import authorisation, or pharmacy premises authorisation.

A manufacturing licence holder must maintain control of the nominated persons responsible for production and quality control; personnel changes must be notified as soon as possible. Queensland wholesale applications identify relevant business personnel; there is no national educational qualification or staffing ratio that can safely be applied generally.

— Maintain a responsibility register for pharmacists, nominated manufacturing personnel, wholesale-related personnel and ODC contacts.

— When personnel/directors change, first determine whether notification, amendment or a new application is required.

Swipe horizontally to view all items

The national Code requires wholesale buildings and receiving/dispatch areas to protect medicines and provide necessary segregation areas; temperature must be controlled according to labels and recorded, and personnel, SOP, transport, recall and security controls must be established. It does not set a national minimum floor area.

A manufacturing licence is linked to the site, activities and GMP; Victoria may review a pharmacy's facilities, equipment, security, management and service floor plans, while Queensland wholesale storage sites must have an SMP. This does not cover all premises standards in every jurisdiction.

— Include pharmacy, warehouse, 3PL, manufacturing and QC sites individually in the authorisation checks.

— Prepare plans, temperature controls, security and SOPs according to product risk.

Swipe horizontally to view all items

Applications should be separated: first assess the product sponsor and ARTG inclusion/exemption; Australian manufacturing follows the TGA and GMP pathway; retail/wholesale applications are submitted according to the proposed state/territory of operation. Queensland wholesale applications require supporting documents and a list of relevant persons; NSW applications may require probity checks, declarations or control procedures. These are not a nationally uniform checklist.

For cross-border controlled substances, apply separately to the ODC; information includes company/ASIC details, state certificates, storage security, transport, theft and authorised contacts. Declaring proposed import/export activities does not itself authorise shipment.

— First classify the product, activity, site and personnel.

— Do not treat a proposed activity as authorised to operate before written authorisation is obtained.

Swipe horizontally to view all items

Do not invent nationally uniform fees, durations or approval times. TGA guidance states that a manufacturing licence application in Australia, including inspection, may take up to 12 months to complete, and overseas GMP certification may take up to 15 months; these figures are for planning only. Manufacturing licence holders also have an annual charge.

The NSW page states that a complete application may take up to 90 days and that fees apply to new applications, renewals and amendments; Victoria also has annual renewals. These are local or pathway-specific details and must not be generalised.

— Prepare the budget using the fee schedule in force on the submission date, the application type and the licence conditions.

— Determine when it takes effect by reference to written approval, not an estimate or settlement date.

Swipe horizontally to view all items

TGA manufacturing licence holders must comply with GMP, standards and conditions, and maintain production/QC controls, records, cooperation with inspections, the annual charge and CAPA. Records are generally retained until at least 12 months after expiry; where there is no expiry date, they are generally retained for at least 6 years, although the GMP Code may require longer.

Ongoing wholesale controls include training, temperature control, inventory, transport, recalls, documentation and security. State-level renewal and reporting requirements differ; NSW requires immediate notification of the loss or theft of specified high-risk substances, and Queensland storage locations must comply with the SMP.

— Establish self-inspection plans for GMP, cold chain, recalls, deviations, CAPA and controlled substances.

— Maintain a list of licence expiry dates, contacts and conditions.

Swipe horizontally to view all items

A manufacturing licence cannot be transferred arbitrarily, partially or automatically. If a business is sold, or a change of ownership including a share sale includes the licence, the acquirer must notify the TGA within 3 months after the transfer and submit evidence of the transaction. If the licence is not acquired as part of a disposal of the business, a new licence must be applied for before manufacturing.

A change of ARTG sponsor must be notified separately to the TGA. NSW states that material changes, such as changes to the entity name, site, conditions, activities or cold chain, may require a new application; Victoria has a notification form for the transfer or sale of pharmacy ownership.

— Before the transaction, list the manufacturing licence, ARTG entries, state-level premises/business licences and ODC permits.

— Assess notification, amendment, transfer or new-application requirements item by item.

Swipe horizontally to view all items

Therapeutic goods generally must be entered in the ARTG before they can lawfully be imported, supplied or exported, unless an exemption applies. The sponsor of an ARTG entry is responsible for applying for and maintaining it. Accordingly, a pharmacy or warehouse authorisation does not mean that any product may be imported or sold.

Importing/exporting controlled narcotic drugs, psychotropic substances or precursors also requires an ODC licence and/or permit, alongside state/territory restrictions on possession, storage and wholesale. Compounding exemptions are narrow and do not circumvent ARTG, manufacturing or controlled-drug rules.

— Verify the ARTG entry, sponsor, labelling, manufacturing site and importer for each SKU.

— For controlled ingredients, also verify ODC requirements, state-level authorisation, security and customer eligibility.

Swipe horizontally to view all items